Question: There seem to be some potential problems in valuing ULG's. I mean, the non-financial risk is a concern, there is no (what I am aware of) market for mortality exposure and longevity? If the benefits are linked to such events in a non-Symantec way, will finding market prices prove problematic?
Answer: Mark Hayhoe There are a number of risks that we, as providers, take into account when pricing and managing ULGs. The capital market risks include changes in asset value; changes in interest rates; volatility in asset values; interactions between risks; lesser order effects etc. These risks can be managed by purchasing financial instruments which increase in value to match a corresponding increase in value of the guarantees. These financial instruments have to be regularly adjusted and re-balanced to take account of movements in our book of business. You are correct tha...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
